Literature DB >> 7631024

Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up.

B Rasmusson1, I Vejborg, A B Jensen, M Andersson, A M Banning, T Hoffmann, P Pfeiffer, H K Nielsen, P Sjøgren.   

Abstract

The results from a prospective randomized trial comparing two different radiation schedules for treatment of painful bone metastases in women with recurrent breast cancer are presented. A total of 217 patients with painful bone metastases were randomized to either 30 Grey (Gy) in ten fractions, five fractions a week (5F/W) or 15 Gy in three fractions 2F/W. The effect of treatment was evaluated by pain assessment, the radiological response and the degree of side-effects. The patients were rated at start of treatment and after 1, 3, 6 and 12 months. No difference between the two radiation regimes was found, neither in achieved pain relief, improvement in level of activity and medication, nor was there any difference in radiological response and side-effects from treatment. Both regimes resulted in a significant improvement in both pain score and level of activity 1 month after treatment, an improvement which persisted during the follow-up period. We conclude that 15 Gy given in three fractions 2F/W is as effective as 30 Gy in ten fractions 5F/W, but more convenient to the patient and of less cost to society.

Entities:  

Mesh:

Year:  1995        PMID: 7631024     DOI: 10.1016/0167-8140(95)01520-q

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  11 in total

Review 1.  WITHDRAWN: Radiotherapy for the palliation of painful bone metastases.

Authors:  Henry J McQuay; Sally L Collins; Dawn Carroll; R Andrew Moore; Sheena Derry
Journal:  Cochrane Database Syst Rev       Date:  2013-11-22

2.  Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation.

Authors:  Jonathan Karnon; Jackie Brown
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 3.  Treatment of painful bone metastases.

Authors:  Dirk Rades; Steven E Schild; Janet L Abrahm
Journal:  Nat Rev Clin Oncol       Date:  2010-03-16       Impact factor: 66.675

4.  Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012.

Authors:  N Thavarajah; L Zhang; K Wong; G Bedard; E Wong; M Tsao; C Danjoux; E Barnes; A Sahgal; K Dennis; L Holden; N Lauzon; E Chow
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

5.  Dose-Fractionation Schedules for Radiotherapy of Bone Metastases.

Authors:  Dirk Rades
Journal:  Breast Care (Basel)       Date:  2010-10-15       Impact factor: 2.860

6.  European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey.

Authors:  Nicolas Magné; Cyrus Chargari; René Olivier Mirimanoff; Pierre Olivier; Jean Philippe Vuillez; Michèle Tubiana-Hulin; Jean Jacques Body; Jean Léon Lagrange
Journal:  Support Care Cancer       Date:  2010-08-31       Impact factor: 3.603

7.  Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.

Authors:  Andre Konski; Jennifer James; William Hartsell; Mark H Leibenhaut; Nora Janjan; Walter Curran; Mack Roach; Deborah Watkins-Bruner
Journal:  Am J Clin Oncol       Date:  2009-08       Impact factor: 2.339

Review 8.  Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy.

Authors:  Caterina Fontanella; Valentina Fanotto; Karim Rihawi; Giuseppe Aprile; Fabio Puglisi
Journal:  Clin Exp Metastasis       Date:  2015-09-07       Impact factor: 5.150

9.  Contemporary radiooncological management of bone metastases from breast cancer: factors associated with prescription of different fractionation regimens (short or long course) in a rural part of North Norway with long travel distance.

Authors:  Carsten Nieder; Astrid Dalhaug; Ellinor Haukland; Bård Mannsåker; Adam Pawinski
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

10.  Continuous controversy about radiation oncologists' choice of treatment regimens for bone metastases: should we blame doctors, cancer-related features, or design of previous clinical studies?

Authors:  Carsten Nieder; Adam Pawinski; Astrid Dalhaug
Journal:  Radiat Oncol       Date:  2013-04-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.